Market Place
Sourcing Support
NextCure To Give Two Presentations At SITC Annual Meeting
04 Oct 2024 //
GLOBENEWSWIRE
NextCure Presented NC410 Phase 1b Results At ESMO 2024
16 Sep 2024 //
GLOBENEWSWIRE
NextCure Reports Q2 2024 Results And Provides Business Update
01 Aug 2024 //
GLOBENEWSWIRE
NextCure To Present At HC Wainwright 5th Annual Neuro Perspectives Event
20 Jun 2024 //
GLOBENEWSWIRE
NextCure Presents NC410-Pembrolizumab Combo Data At ASCO 2024
30 May 2024 //
GLOBENEWSWIRE
NextCure Q1 2024 Results, Business Update
02 May 2024 //
GLOBENEWSWIRE
NextCure to Present NC410 + Pembrolizumab Phase 1b Data at ASCO 2024
24 Apr 2024 //
GLOBENEWSWIRE
NextCure and LCB Present Preclinical Data on B7-H4 ADC at AACR 2024
08 Apr 2024 //
GLOBENEWSWIRE
NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board
04 Apr 2024 //
GLOBENEWSWIRE
NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference
02 Apr 2024 //
GLOBENEWSWIRE
NextCure Provides Business Update and Reports Full Year 2023 Financial Results
21 Mar 2024 //
GLOBENEWSWIRE
NextCure to lay off 37% of staff, dial back research plans
21 Mar 2024 //
BIOPHARMADIVE
NextCure Publishes Data Demonstrating Function of FLRT3
05 Mar 2024 //
GLOBENEWSWIRE
NextCure Presents Data on a Novel Therapeutic Candidate Targeting VSTM-1
18 Jan 2024 //
GLOBENEWSWIRE
NextCure Publishes Data Showing Anti-Siglec-15 Treatment Prevented Bone Loss
21 Dec 2023 //
GLOBENEWSWIRE
NextCure Provides Year-End Clinical Pipeline Updates
14 Dec 2023 //
GLOBENEWSWIRE
NextCure jettisons mAB to focus on ADC aimed at same target
14 Dec 2023 //
FIERCE BIOTECH
NextCure to Present at the 35th Annual Piper Sandler Healthcare Conference
20 Nov 2023 //
GLOBENEWSWIRE
NextCure Publishes Non-Clinical Data Defining the Mechanism of Action for NC525
15 Nov 2023 //
GLOBENEWSWIRE
NextCure Reports Third Quarter 2023 Financial Results
02 Nov 2023 //
GLOBENEWSWIRE
Preclinical Data Demonstrate Anti-Siglec-15 Treatment Reduced Bone Loss
17 Oct 2023 //
GLOBENEWSWIRE
NextCure Presents Preclinical Data on NC181
26 Sep 2023 //
GLOBENEWSWIRE
A Phase 2 Study of NC318 with Pembrolizumab Demonstrates Clinical Activity
12 Sep 2023 //
GLOBENEWSWIRE
NextCure and Nordic Publish Article on the Regulation of Tumor Immunity
07 Sep 2023 //
GLOBENEWSWIRE
Preclinical Data Shows Application of Anti-Siglec-15 Treatment in Bone Disease
05 Sep 2023 //
GLOBENEWSWIRE
NextCure to Present at the H.C. Wainwright 25th Annual Conference
31 Aug 2023 //
GLOBENEWSWIRE
NextCure Reports Second Quarter 2023 Financial Results
03 Aug 2023 //
GLOBENEWSWIRE
NextCure Presents Non-Clinical Data Defining the Mechanism of NC525
21 Jun 2023 //
GLOBENEWSWIRE
NextCure to Present at the JMP Securities Life Sciences Conference
09 May 2023 //
GLOBENEWSWIRE
NextCure Provides Business Update and Reports 1Q FYR 2023
04 May 2023 //
GLOBENEWSWIRE
NextCure to Present at 22nd Annual Needham Virtual Healthcare Conference
11 Apr 2023 //
GLOBENEWSWIRE
NextCure Provides Business Update and Reports Full Year 2022 Financial Results
02 Mar 2023 //
GLOBENEWSWIRE
NextCure to Present at SVB Securities Global Biopharma Conference
07 Feb 2023 //
GLOBENEWSWIRE
NextCure to Present at Upcoming Investor Conferences
22 Nov 2022 //
GLOBENEWSWIRE
NextCure, LegoChem join big-league rivals in ADC race
16 Nov 2022 //
FIERCEBIOTECH
NextCure and LegoChem Biosciences Enter into Collaboration and Agreement
15 Nov 2022 //
GLOBENEWSWIRE
NextCure Presents Initial Data from Clinical Trial of NC762 and a Trial
07 Nov 2022 //
GLOBENEWSWIRE
NextCure discards antibody after candidate flunks phase 2 trial
04 Nov 2022 //
FIERCEBIOTECH
NextCure to Present Trial in Progress Poster for NC525 at the 2022 (ASH)
03 Nov 2022 //
GLOBENEWSWIRE
NextCure Provides Update and Reports Third Quarter 2022 Financial Results
03 Nov 2022 //
GLOBENEWSWIRE
NextCure Appoints Dr. Lisa M. Coussens to Scientific Advisory Board
27 Oct 2022 //
GLOBENEWSWIRE
NextCure to Give Two Presentations at Society for Immunotherapy
05 Oct 2022 //
GLOBENEWSWIRE
NextCure Announces Initiation of Phase 1b/2 Clinical Trial to Evaluate NC410
04 Oct 2022 //
GLOBENEWSWIRE
NextCure to Present at the Ladenburg Thalmann Healthcare Conference
22 Sep 2022 //
GLOBENEWSWIRE
NextCure Announces Development of Highly Specific Immunohistochemical Diagnostic
06 Jul 2022 //
GLOBENEWSWIRE
NextCure Presented NC410 Data at ECM Pharmacology Congress in Europe
27 Jun 2022 //
GLOBENEWSWIRE
NextCure Reports First Quarter 2022 Financial Results
05 May 2022 //
GLOBENEWSWIRE
NextCure to Present at the BofA Securities 2022 Healthcare Conference
03 May 2022 //
GLOBENEWSWIRE
NextCure and NCI Announce Preclinical Data in Journal of Clinical Investigation
19 Apr 2022 //
GLOBENEWSWIRE
NextCure Reports Fourth Quarter and Full Year 2021 Financial Results
03 Mar 2022 //
GLOBENEWSWIRE
NextCure to Present at Piper Sandler 33rd Annual Virtual Healthcare Conference
22 Nov 2021 //
GLOBENEWSWIRE
NextCure and Collaborators Provide Clinical& Research Updates on NC318 and NC410
13 Nov 2021 //
GLOBENEWSWIRE
NextCure Announces Presentations on Development by Collaborators at ASH
04 Nov 2021 //
GLOBENEWSWIRE
NextCure to Host Virtual Oncology Pipeline Update Event on Nov
01 Nov 2021 //
GLOBENEWSWIRE
NextCure Initiates Phase 1/2 Clinical Trial of NC762 for Solid Tumors
06 Jul 2021 //
GLOBENEWSWIRE
NextCure & Collaborators Publish Preclinical Data on Novel Immunomedicine NC410
21 Jun 2021 //
GLOBENEWSWIRE
NextCure to Present Trials in Progress Poster for NC410 at the 2021 (ASCO)
18 May 2021 //
GLOBENEWSWIRE
NextCure hires Celgene vet as CMO; José Vega leaves Merck to become Moderna`s
15 Jan 2021 //
ENDPTS
NextCure Provides Updates on NC318 Clinical Program
17 Dec 2020 //
GLOBENEWSWIRE
NextCure Provides Updates on NC318 Clinical Program
17 Dec 2020 //
GLOBENEWSWIRE
